Compare STXS & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STXS | EARN |
|---|---|---|
| Founded | 1990 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.0M | 189.7M |
| IPO Year | 2004 | 2013 |
| Metric | STXS | EARN |
|---|---|---|
| Price | $2.45 | $5.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $4.00 | ★ $5.88 |
| AVG Volume (30 Days) | ★ 414.9K | 320.7K |
| Earning Date | 11-11-2025 | 02-20-2026 |
| Dividend Yield | N/A | ★ 18.11% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $30,075,000.00 | ★ $35,893,000.00 |
| Revenue This Year | $24.48 | $8.43 |
| Revenue Next Year | $29.98 | $17.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 19.62 | ★ 43.30 |
| 52 Week Low | $1.54 | $4.33 |
| 52 Week High | $3.59 | $6.86 |
| Indicator | STXS | EARN |
|---|---|---|
| Relative Strength Index (RSI) | 51.47 | 53.20 |
| Support Level | $2.30 | $5.15 |
| Resistance Level | $2.42 | $5.20 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 72.73 | 63.35 |
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.